Parkway Cancer Centre

What Parkway Cancer Centre does

Parkway Cancer Centre is a private, for-profit specialty oncology centre founded in 2006 and headquartered in Singapore, operating as part of the Parkway Group within IHH Healthcare — one of Asia's largest integrated private healthcare networks. The centre delivers comprehensive cancer care across the full clinical pathway: medical oncology, surgical oncology (including laparoscopic and robot-assisted procedures), haematology oncology, radiation oncology (including intensity-modulated and proton beam therapy), and palliative medicine, supported by cancer screening, clinical trials, and a patient-assistance programme. Treatment modalities span chemotherapy, targeted therapy, immunotherapy, CAR T-cell therapy, hyperthermia, and stem cell / bone marrow transplantation.

Services are physically delivered through four flagship IHH hospitals in Singapore — Gleneagles, Mount Elizabeth, Mount Elizabeth Novena, and Parkway East — and the centre runs a dedicated international patient programme with multilingual support across nine markets (Singapore, Bangladesh, India, Indonesia, Malaysia, Myanmar, Philippines, Sri Lanka, UAE, Vietnam). The CanHOPE non-profit programme provides counselling, support groups, nutrition, rehabilitation, and survivor communities that extend the centre's reach beyond acute treatment episodes. Pricing is not publicly disclosed; the centre accepts payments via Singapore healthcare financing schemes (MediShield Life, Integrated Shield Plans, MediSave, MediFund, corporate insurance) and through partnerships with five major insurers (AIA, Great Eastern, HSBC Life, Income, Singlife). The customer base is fundamentally long-tail — individual patients and international self-pay or insured medical tourists — with no disclosed enterprise contract concentration.

Go-to-market combines content marketing via a multilingual SEO-optimised website, a cancer counselling hotline, WhatsApp and email appointment booking, community engagement through CanHOPE, and continuing medical education for referring professionals. The business model is professional-services revenue from consultations, treatment procedures, screening, and clinical trials, with the IHH network providing hospital-level infrastructure, referral pipelines, and back-office functions. Revenue and headcount are not publicly disclosed at the centre level.

Name

Parkway Cancer Centre

Legal name

Parkway Cancer Centre

Website

https://parkwaycancercentre.com

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

11–50 employees

Short description

Parkway Cancer Centre is a Singapore-based private specialty oncology centre, part of IHH Healthcare, delivering comprehensive cancer diagnosis, treatment (including chemotherapy, radiation, proton therapy, and CAR T-cell), and palliative care across four Parkway hospitals and serving international patients from nine Asian and Middle Eastern markets.

Ownership category

akta.pro rank

Product category

Oncology Treatment Services

NAICS

Ambulatory Health Care Services (621), Specialty (except Psychiatric and Substance Abuse) Hospitals (62231)

SIC

Services-Hospitals (8060), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)

akta.pro secondary industries

Medical Oncology (HLAKAFAB), Oncology & Cancer Specialty Hospitals (HLAFAHAC), Hospital-Based Palliative Care (Inpatient Consult Services) (HLADAHAG)

Keywords

• Oncology treatment services
• Cancer care center
• Radiation oncology
• Surgical oncology
• Cancer screening services

Headquarters

HQ city

Singapore

HQ country

Singapore

HQ region

Asia

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Medical Consultation Services: Fees from consultations with oncologists and cancer specialists across multiple disciplines (medical oncology, surgical oncology, haematology oncology, radiation oncology)
2. Cancer Treatment Procedures: Revenue from chemotherapy, targeted therapy, immunotherapy, radiation therapy, surgical procedures, stem cell transplants, and other cancer treatments
3. Cancer Screening Services: Revenue from cancer screening programmes and diagnostic services
4. Clinical Trial Services: Revenue from clinical trial programmes for experimental treatments

Go-to-market motion1 record

Distribution channels5 records

Marketing channels4 records

Core offering

Parkway Cancer Centre is a private oncology centre that diagnoses and treats cancer through medical oncology, surgical oncology, haematology oncology, radiation oncology, and palliative medicine, supported by cancer screening and clinical trials. It delivers specific treatment modalities including chemotherapy, targeted therapy, immunotherapy, CAR T-cell therapy, proton beam therapy, hyperthermia, and stem cell/bone marrow transplantation across four Parkway Pantai hospitals in Singapore. CanHOPE provides complementary non-profit counselling, emotional support, support groups, and palliative care services, with dedicated international patient guides serving patients from South, Southeast Asia, and the Middle East.

Product overview

Parkway Cancer Centre is a comprehensive cancer treatment center providing integrated oncology services through a multi-disciplinary approach. The centre offers a portfolio of core treatment services including Medical Oncology, Surgical Oncology, Haematology Oncology, Radiation Oncology, and Palliative Medicine, complemented by Cancer Screening for early detection. These core services are supported by specific treatment modalities including Chemotherapy, Targeted Therapy, Immunotherapy, CAR T-cell Therapy, Proton Therapy, Hyperthermia, and Stem Cell Therapy/Bone Marrow Transplant. Additionally, the centre provides patient support through CanHOPE (a cancer counselling and support service), Patient Assistance Programmes, and access to Clinical Trials. The centre's hospital network includes Gleneagles, Mount Elizabeth, Mount Elizabeth Novena, and Parkway East Hospital.

Differentiator

Problem solved

Functional benefit

Brands

• CanHOPE: A non-profit cancer counselling and support service provided by Parkway Cancer Centre, Singapore. Provides cancer information, referrals, counselling, emotional support, support group activities, and palliative care services.

Products and services

• Medical Oncology Systemic therapy using oncology medicines to treat cancer for patients across all cancer types, delivered by medical oncology specialists.
• Surgical Oncology Surgical removal of cancerous tumours and tissue using laparoscopic, robot-assisted, and open surgery methods for cancer patients.
• Haematology Oncology Specialised diagnosis and treatment of blood cancers including leukaemia and lymphoma for patients worldwide.
• Radiation Oncology Radiation therapy using focused beams to target malignant and benign tumours while minimising effects on surrounding tissue, including intensity-modulated radiation therapy (IMRT) and proton beam therapy.
• Palliative Medicine Care that minimises suffering and improves quality of life by relieving pain, symptoms, and stress for patients with serious illnesses and advanced cancer.
• Cancer Screening Screening services that detect cancer before symptoms appear, enabling early diagnosis and treatment.
• Chemotherapy Use of potent chemical compounds (cytotoxic drugs) to destroy cancer cells or stop them from growing, administered intravenously, orally, intraperitoneally, intrathecally, or intravesically.
• Targeted Therapy Precision medicine using drugs designed to target specific molecular changes or substances in cancer cells, including Trastuzumab, Osimertinib, Bevacizumab, Bortezomib, and Olaparib.
• Immunotherapy Treatment that boosts the body's immune system to find and destroy cancer cells using medications or genetically engineered immune cells.
• CAR T-cell Therapy Advanced immunotherapy that genetically engineers a patient's own T-cells to recognise and attack cancer cells.
• Proton Therapy Advanced external radiation therapy using proton streams to deliver more radiation to cancer cells with less damage to nearby healthy tissues.
• Hyperthermia Cancer treatment that uses controlled heat to damage and kill cancer cells while minimising harm to normal tissue.
• Stem Cell Therapy / Bone Marrow Transplant Transplant of blood-forming stem cells (autologous or allogeneic donor) to restore blood cells in patients who have undergone chemotherapy or radiotherapy.
• Clinical Trials Access to clinical trial programmes for experimental cancer treatments and therapies for eligible patients.
• Patient Assistance Programmes Programmes that assist patients with financing and access to cancer treatment services, including coordination with Singapore healthcare financing schemes and insurance partners.
• CanHOPE Cancer Counselling and Support Non-profit cancer counselling and support service providing cancer information, referrals, emotional support, support group activities, and palliative care services to patients and families.

Quantifiable outcome

• High survival rates for early-stage cancers: Stage 1 breast cancer near 100% 5-year survival; Stage 1 kidney cancer ~90% 5-year survival; Stage 1 ovarian cancer ~90% 5-year survival
• +1 more outcomes

Named customers5 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

Ten partnerships are on record, tiered core.

• Gleneagles HospitalcoreStrategic or Co-development PartnerGleneagles Hospital is part of the Parkway Pantai/IHH Healthcare network and hosts Parkway Cancer Centre services. Patients receive integrated cancer care within this hospital setting.
• Mount Elizabeth HospitalcoreStrategic or Co-development PartnerMount Elizabeth Hospital is part of the Parkway Pantai/IHH Healthcare network and hosts Parkway Cancer Centre services. One of the leading private hospitals in Singapore for cancer treatment.
• Mount Elizabeth Novena HospitalcoreStrategic or Co-development PartnerMount Elizabeth Novena Hospital is part of the Parkway Pantai/IHH Healthcare network and hosts Parkway Cancer Centre services. Provides comprehensive oncology services in a modern facility.
• Parkway East HospitalcoreStrategic or Co-development PartnerParkway East Hospital is part of the Parkway Pantai/IHH Healthcare network and hosts Parkway Cancer Centre services. Provides accessible cancer care services.
• CanHOPEcoreStrategic or Co-development PartnerCanHOPE is a non-profit cancer counselling and support service provided by Parkway Cancer Centre. It provides comprehensive cancer information, referrals, counselling, emotional support, support groups, and palliative care services.
• AIAcoreChannel Partner/ Reseller/ DistributorAIA is an insurance partner of Parkway Cancer Centre. AIA policyholders can access cancer treatment services with insurance coverage.
• Great EasterncoreChannel Partner/ Reseller/ DistributorGreat Eastern is an insurance partner of Parkway Cancer Centre. Great Eastern policyholders can access cancer treatment services with insurance coverage.
• HSBC LifecoreChannel Partner/ Reseller/ DistributorHSBC Life is an insurance partner of Parkway Cancer Centre. HSBC Life policyholders can access cancer treatment services with insurance coverage.
• IncomecoreChannel Partner/ Reseller/ DistributorIncome is an insurance partner of Parkway Cancer Centre. Income policyholders can access cancer treatment services with insurance coverage.
• SinglifecoreChannel Partner/ Reseller/ DistributorSinglife is an insurance partner of Parkway Cancer Centre. Singlife policyholders can access cancer treatment services with insurance coverage.

Scale indicators1 record

Recent moves1 record

Expansion highlights4 records

Regional players

• Apollo Hospitals (Apollo Cancer Centres): India's largest hospital network with dedicated Apollo Cancer Centres offering medical, surgical, and radiation oncology across multiple cities. Competes with Parkway Cancer Centre for cost-sensitive South Asian patients who would otherwise travel to Singapore.
• Bumrungrad International Hospital: Bangkok-based tertiary hospital widely regarded as Asia's leading medical-tourism destination. Competes with Parkway Cancer Centre for international cancer patients from the Middle East, South Asia, and Southeast Asia.
• Asiri Hospitals (Asiri Cancer Centre): Sri Lanka's leading private hospital group with a dedicated cancer centre. Comparable private multidisciplinary oncology provider in a nearby source market for Parkway Cancer Centre's international patient funnel.
• Subang Jaya Medical Centre (Ramsay Sime Darby): Malaysian tertiary private hospital with an established cancer centre serving Malaysian patients and Indonesian medical tourists. Comparable in offering multidisciplinary private oncology in a nearby geography.

Others

• Gleneagles Hospital Singapore: Another sister IHH Healthcare facility hosting Parkway Cancer Centre services. Important context for understanding distribution and capacity allocation within the same group.
• Mount Elizabeth Hospital (Novena & Orchard): Sister IHH Healthcare hospitals hosting Parkway Cancer Centre services. Although not an external competitor, they share infrastructure, brand, and patient flow with the centre and shape its competitive dynamics.

Direct peers

• Farrer Park Hospital: Singapore private hospital with an integrated oncology centre serving local and regional patients. Competes head-to-head with Parkway Cancer Centre for medical-tourism cancer cases in Singapore.
• National Cancer Centre Singapore (NCCS): Singapore's largest public-sector comprehensive cancer centre offering multidisciplinary oncology across medical, radiation, surgical, and haematology services. Directly comparable in service scope, but operates on a public-subsidised model rather than private-pay.
• Thomson Hospital (Thomson Medical Group): Malaysia-based private hospital group with growing oncology capabilities catering to cross-border patients from Singapore and the region. Comparable private oncology provider targeting Southeast Asian medical-tourism flows.
• Raffles Hospital (Raffles Medical Group): Singapore private hospital group operating a dedicated Raffles Cancer Centre offering medical, radiation, and surgical oncology. Closest like-for-like private competitor in the same Singapore catchment serving local and international patients.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/ParkwayCancerCentre
• LinkedInlinkedin.com/company/parkway-cancer-centre

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Parkway Cancer Centre